Drugs / A/H5N1 inactivated, split-virion influenza vaccine
A/H5N1 inactivated, split-virion influenza vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00457509 Comparator | Jan 2007 → Nov 2009 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A/H5N1 inactivated, split-virion influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00457509 ↗ |
| Modality | Vaccine | “H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine” NCT00457509 ↗ |
| Route | Intramuscular | “Intramuscular” NCT00457509 ↗ |